Mucilages are heterogeneous mixtures of complex carbohydrates , including arabinose, galactose, rhamnose, uronic acids, and related sugar units , that form colloidal gels on contact with water. They are distinct from gums (which exude from wounds) and from starches (which are intracellular storage polymers), though all three are polysaccharide families. Botanically, mucilages are synthesised within specialised cells, seed coats, and root tips, where they are understood to assist in water retention, germination, and physical protection of plant tissues.
Across a wide range of plant families, mucilaginous material is concentrated in seeds, leaves, roots, or bark. Common botanical sources studied in the phytochemical literature include Althaea officinalis (marshmallow root), Ulmus rubra (slippery elm bark), Plantago ovata seed husks, Linum usitatissimum (linseed), and various Malvaceae and Cactaceae species. The proportion and precise monosaccharide composition of mucilage varies considerably between species and plant parts, and these structural differences influence physical properties such as viscosity, gel strength, and solubility profile.
In phytochemical analysis, mucilages are typically isolated by aqueous extraction followed by precipitation with ethanol, then characterised by methods including gas chromatography–mass spectrometry (GC-MS) of hydrolysed monosaccharide residues, nuclear magnetic resonance (NMR) spectroscopy, and rheological measurement. Regulatory classification of mucilage-containing plant material in Australia falls under the Therapeutic Goods Act 1989 and associated Therapeutic Goods (Permissible Ingredients) Determination, administered by the Therapeutic Goods Administration (TGA); listed complementary medicines containing mucilaginous herbal ingredients must comply with TGA listing requirements and evidence standards applicable to their dosage form and claims.
Research into plant mucilages is ongoing in the fields of food science, pharmaceutical excipient development, and phytochemistry. Mucilages have been investigated as natural hydrocolloids for film-forming, binding, and sustained-release applications in pharmaceutical technology. Any representation that a mucilage-containing product treats or prevents a disease or health condition in Australia must comply with the TGA's evidence framework and the Therapeutic Goods Advertising Code.
Sources: